Professional
Added to YB: 2025-05-28
Pitch date: 2025-03-31
VETO.PA [neutral]
Vetoquinol SA
+4.55%
current return
Author Info
No bio for this author
Company Info
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
Market Cap
EUR 819.4M
Pitch Price
EUR 75.85
Price Target
85.00 (+7%)
Dividend
1.32%
EV/EBITDA
5.60
P/E
14.28
EV/Sales
1.17
Sector
Pharmaceuticals
Category
value
The Gabelli Pet Parent's Fund Portfolio Holding: Vetoquinol SA
VETO.PA (earnings update): Global animal health pharma co specializing in vet products. Notable products: Phovia light therapy & Zylkene calming supplement. Generated significant 2024 cash flow via margin expansion & product mix improvements. PMV of €85 vs current €77.80.
Read full article (1 min)